Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Turning Pennies into dollars: (Nasdaq: CEGE), (NASDAQ: ACUS), (OTCBB: XDSL).
- M2 PRESSWIRE-2 April 2008-RealPennies.com: Turning Pennies into dollars: (Nasdaq: CEGE), (NASDAQ: ACUS), (OTCBB: XDSL).C1994-2008 M2 COMMUNICATIONS LTD RDATE:02042008 Are you a public company looking for exposure? Contact RealPennies.com - 1.800.940.6559 For more info: http://cege.realpennies.com ...
- Research articles 2008-04-02
- STHG, CEGE, ACUS, XDSL - OTCStockExchange.com Stock Alert.
- M2 PRESSWIRE-1 April 2008-otcstockexchange.com: STHG, CEGE, ACUS, XDSL - OTCStockExchange.com Stock AlertC1994-2008 M2 COMMUNICATIONS LTD RDATE:01042008 Rochester, NY -- OTCStockExchange.com's "Stock Watch Alert" this morning are Steadfast Holdings Group, Inc. (Pink Sheets: STHG), Cell Genesys, Inc. (Nasdaq: CEGE), Acusphere Inc....
- Research articles 2008-04-01
- Andrx Corporation Reports Financial Results for 2006 First Quarter
- FORT LAUDERDALE, Fla. -- Andrx Corporation (Nasdaq:ADRX) ("Andrx" or the "Company") today announced its financial results for the three months ended March 31, 2006 (the "2006 Quarter"), which are discussed more extensively in Andrx's Form 10-Q for the 2006 Quarter ("March 2006 10-Q") being filed today with the U.S. Securities...
- Research articles 2006-05-04
- Takeda Pharmaceutical Receives FDA Fast Track Designation for TAK-
- Tokyo, July 29, 2005 - JCN - Takeda Pharmaceutical announced on July 27 that one of its US affiliates, Takeda Global Research & Development Center of Illinois, has received fast track designation by the US Food and Drug Administration FDA for TAK-242, its investigational compound designed for the treatment of...
- Research articles 2005-07-29
- Takeda Responds to the FDA Advisory Committee Recommendation
- Following a joint meeting today of the U.S. Food and Drug Administration FDA Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee, Takeda Global Research & Development TGRD underscores its position that ACTOS® pioglitazone HCl offers a proven safety profile regarding the risk of...
- Research articles 2007-07-30
- Sumitomo Chemical and Takeda To Form Business Alliance; Takeda To Transfer Its Agrochemicals Business To A New Joint Venture Company
- Business Editors
- Research articles 2002-07-31
- Amgen and Takeda Announce Exclusive Collaboration in Japan on up to 13 Amgen Clinical Candidates
- Amgen to Receive $200 Million Upfront Payment, $702 Million in Multi-year Global R&D Expense Sharing and Success-based Milestones, and Double Digit Royalties on Japan Sales; Takeda Will Receive Exclusive Rights to Develop and Commercialize Select Molecules in Japan
- Research articles 2008-02-04
- Takeda Responds to the FDA Advisory Committee Recommendation.
- LONDON, July 31 /PRNewswire/ -- LONDON, July 31 /PRNewswire/ --
- Research articles 2007-07-31
- Takeda Pharmaceutical, Wyeth Launches ENBREL Anti-rheumatic Agent
- Takeda Pharmaceutical (TSE: 4502) and Wyeth jointly announced on March 29 that they will begin distributing ENBREL, an injection solution for the treatment of rheumatoid arthritis RA, on March 30.
- Research articles 2005-03-31
- Takeda Pharmaceutical, Hitachi Jointly Establish New Information
- Tokyo, Feb 20, 2006 - JCN - Takeda Pharmaceutical and Hitachi jointly announced February 20 the establishment of Hitachi Inspharma, Ltd., a joint venture to support and develop information systems for the medical and pharmaceutical industries.
- Research articles 2006-02-20
- 3M Pharmaceuticals and Takeda to Collaborate on Potential Treatment for Cervical High-Risk HPV Infection and Cervical Dysplasia
- ST. PAUL, Minn. & OSAKA, Japan -- 3M and Takeda Pharmaceutical Company Limited Takeda announced today that the two companies entered into an exclusive co-development and joint marketing agreement to collaborate on a potential topical treatment for cervical high-risk human papillomavirus HPV infection and cervical dysplasia.
- Research articles 2005-03-01
- Hitachi, Takeda Pharmaceutical to Establish Information System
- Tokyo, Oct 7, 2005 - JCN - Hitachi and Takeda Pharmaceutical jointly announced on October 3 that the two companies have basically agreed to establish a joint venture company for information system service as of September 29.
- Research articles 2005-10-07
- BASF and Takeda Combine.(Brief Article)
- BASF Akt, Ludwigshafen, tel:+49 621 60-9 9938, and Takeda Chemical Industries Ltd, Osaka, Japan, have agreed to combine their bulk vitamins businesses, which includes transferring part of Takeda's assets. The agreement has been approved by the respec BASF Akt, Ludwigshafen, tel:+49 621 60-9 9938, and Takeda...
- Research articles 2000-09-01
- HEY, ABBOTT! YOUR ALLY GOES IT ALONE: TAKEDA'S U.S. DRIVE STARTS HERE.
- Takeda Chemical Industries Ltd., Japan's largest drug company, is making an aggressive push into the U.S. market and using a new office here as its launching pad. Takeda Pharmaceuticals America Inc. TPA, a newly created marketing unit of the Jap Takeda Chemical Industries...
- Research articles 1999-03-01
- Sumitomo, Takeda form ag chemicals venture. (News).(Japan's largest drug manufacturer forms joint venture with Sumitomo Chemical Company Ltd.)(International Pages)(Brief Article)
- SUMITOMO CHEMICAL Company Ltd. and Takeda Chemical Industries Ltd. have formed a joint venture in agrochemicals, Sumika Takeda Agrochemical Company Ltd. The new company will be based in Tokyo and operate as a joint venture company for five years. S SUMITOMO CHEMICAL Company Ltd....
- Research articles 2002-08-05
- Kyocera, Osaka Achieve 44%.(Osaka Gas Company Ltd.; electric cogeneration)
- Osaka Gas Co., Ltd. and Kyocera Corp. (6, Takeda Tobadono-cho, Fushimi-ku, Kyoto, Japan 612-8501; Tel: 075-604-3416) have achieved an AC output power generation efficiency of 44%, according to operational assessments conducted by Osaka Gas. Based on Osaka Gas Co., Ltd. and Kyocera Corp. (6, Takeda...
- Research articles 2004-12-01
- Takeda Responds to the FDA Advisory Committee Recommendation
- DEERFIELD, Ill. -- Following a joint meeting today of the U.S. Food and Drug Administration FDA Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee, Takeda Global Research & Development TGRD underscores its position that ACTOS([R]) pioglitazone HCl offers a proven safety profile regarding...
- Research articles 2007-07-30
- Human Genome Sciences and Takeda complete option and license agreement
- ROCKVILLE, Md. and Osaka, Japan--BUSINESS WIRE--June 27, 1995-- Human Genome Sciences ("HGS") (NASDAQ:HGSI) and Takeda Chemical Industries Ltd., ("Takeda") today announced that they have entered into an Agreement where Takeda has been granted an exclusive option to license a limited number of future HGS products for development and sale in...
- Research articles 1995-06-27
- BASF and Takeda to Merge Bulk Vitamins Units.(Brief Article)
- As PART OF ITS [epsilon]60O million (about $600 million) investment strategy for its vitamins business, BASF Aktiengesellschaft has signed an agreement with Takeda Chemical Industries Ltd. to merge their bulk vitamins businesses in a deal that will As PART OF ITS [epsilon]60O million (about...
- Research articles 2000-07-31
- Comparative Analysis 2000. Top 100 Global Chemical Companies.(sales and employees)(Illustration)(Statistical Data Included)
- Comparative Analysis 2000. Top 100 Global Chemical Companies All in $m except employees. ...
- Research articles 2001-10-15
- << Previous
- page 1 of 2
- Next >>
